Animal Model for Prodromal Parkinson's Disease

Area of Science:

• Neuroscience
• Neurology
• Pharmacology

Background:

• Parkinson's disease (PD) involves dopaminergic neuron loss, leading to motor deficits.
• Non-motor symptoms (NMS) often precede motor symptoms, indicating a potential prodromal stage.
• NMS like olfactory loss, constipation, and REM sleep behavior disorder (RBD) are key indicators.

Purpose of the Study:

• To review animal models that exhibit NMS characteristic of prodromal Parkinson's disease.
• To discuss the significance of these models for developing disease-modifying therapies (DMTs).
• To identify appropriate prodromal PD models for therapeutic development.

Main Methods:

• Review of existing literature on animal models of Parkinson's disease.
• Categorization of models based on NMS manifestation (toxin-based, genetic, alpha-synuclein propagation).
• Analysis of the utility of these models in representing the prodromal phase of PD.

Main Results:

• Various animal models replicate NMS associated with prodromal PD.
• These models include toxin-induced, genetic, and alpha-synuclein propagation approaches.
• The reviewed models offer insights into PD initiation and progression.

Conclusions:

• Animal models displaying prodromal NMS are vital for understanding Parkinson's disease.
• Such models are essential for the development and testing of novel disease-modifying therapies (DMTs).
• Further research into appropriate prodromal PD models will accelerate therapeutic advancements.